Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
about
Pharmacological intervention for irritability, aggression, and self-injury in Autism Spectrum Disorders (ASD)Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes.New Therapeutic Options for Autism Spectrum Disorder: Experimental EvidencesAcute dietary tryptophan manipulation differentially alters social behavior, brain serotonin and plasma corticosterone in three inbred mouse strainsPeer social interaction is facilitated in juvenile rhesus monkeys treated with fluoxetineRegulation of emotional response in juvenile monkeys treated with fluoxetine: MAOA interactionsSleep disturbance as detected by actigraphy in pre-pubertal juvenile monkeys receiving therapeutic doses of fluoxetineThe co-occurrence of autism and attention deficit hyperactivity disorder in children - what do we know?Distinctive behavioral and cellular responses to fluoxetine in the mouse model for Fragile X syndrome.Fluoxetine for Autistic Behaviors (FAB trial): study protocol for a randomized controlled trial in children and adolescents with autism.Challenges in the diagnosis and treatment of depression in autism spectrum disorders across the lifespanAutism, oxytocin and interoceptionQuality of prescribing of antipsychotic medication for people with intellectual disability under the care of UK mental health services: a cross-sectional audit of clinical practice.An update on medication management of behavioral disorders in autism.Pharmacogenomics of autism spectrum disorder.Ketogenic diets improve behaviors associated with autism spectrum disorder in a sex-specific manner in the EL mouse.The Rodent Forced Swim Test Measures Stress-Coping Strategy, Not Depression-like Behavior.Can Bayesian Theories of Autism Spectrum Disorder Help Improve Clinical Practice?Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology.Cognitive performance of juvenile monkeys after chronic fluoxetine treatment.Assessing Risk of Bias in Randomized Controlled Trials for Autism Spectrum Disorder.Methylphenidate for children and adolescents with autism spectrum disorder.Pharmacotherapy of emotional and behavioral symptoms associated with autism spectrum disorder in children and adolescents.Common Defects of Spine Dynamics and Circuit Function in Neurodevelopmental Disorders: A Systematic Review of Findings From in Vivo Optical Imaging of Mouse Models.Low-Dose Fluoxetine in Four Children with Autistic Spectrum Disorder Improves Self-Injurious Behavior, ADHD-Like Symptoms, and Irritability.Allergies in Children with Autism Spectrum Disorder: a Systematic Review and Meta-analysisp38α MAPK signaling drives pharmacologically reversible brain and gastrointestinal phenotypes in the SERT Ala56 mouseDepression in Children and Adolescents with Autism Spectrum Disorder
P2860
Q24186796-8DA4D894-4CA5-4D06-AC88-969D55D8ACF8Q26744037-D3E01F21-A31D-4152-B4E9-BDDFAFBDFA2EQ26771762-D19DD21B-37B2-45E5-B738-91747E79233CQ28384969-D340ED63-A668-4C00-A41D-1CC0DB2907B1Q28394699-BF44006F-356C-44A8-9316-F68FC098A22AQ28396360-2261FA3E-3640-4D36-A6DE-C25DFB4662F2Q30762930-7767B7AD-04B4-4E3F-B151-9385D5F8AF1EQ33569253-D2A8F8A6-7AE7-42EE-8D04-6C59FA754152Q33676486-80CC2F91-FCF8-49B4-B28D-DA0808491FCFQ33794328-27A0D77B-BE37-4CD4-B106-04FEAFDC966FQ35899465-E141C364-A76D-4A74-877B-24BFA92F9918Q36501651-6F1ED322-4E0B-43DB-93F7-B2E77EBCB5C5Q37517352-2E47C8A4-C2EC-4A74-BCF6-3A2EFA5FD45EQ38184482-AEEDB6E4-90B8-452A-9093-83C590B8F686Q39154436-BDA1742A-84E6-4BFF-8A2E-C0720E728B7FQ39164229-E83AE165-EEC5-43BC-B633-F7762B68436CQ39175847-3611F3C2-2821-4460-96FF-CC3317A8C419Q39631370-25D49F39-38A7-4D60-8F46-9C13FFE5C1E4Q46111793-E4B1FDBF-C318-41A6-812E-EE0B8D34B8CAQ46639074-90F246CF-2969-4F0E-B4F5-325BE5BB0CE3Q47141355-788A6823-026C-44A0-ADE4-9C441F473737Q47437452-92FA9500-C51A-41B1-9479-CFB2A19D4C44Q49332454-0F1B4790-E9D9-41F0-8367-BDAEB9B63CFEQ55474439-D499FFE6-E4C7-4DCE-AC68-0AC79E58DDDDQ55555544-485A56A1-B5F8-490A-94EB-8720285668FFQ56759954-E6EF0540-6F06-4B4C-837E-831BAED3D6F0Q57295974-9E29B0EE-CBC1-4E92-8F3D-54A2693943B7Q58726336-8383134B-1F5C-493D-8661-5170FBDD2244
P2860
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
@ast
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
@en
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
@en-gb
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
@nl
type
label
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
@ast
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
@en
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
@en-gb
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
@nl
prefLabel
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
@ast
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
@en
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
@en-gb
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
@nl
P2093
P2860
P921
P3181
P1476
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
@en
P2093
Amanda Brignell
Katrina Williams
Melinda Randall
Natalie Silove
P2860
P304
P3181
P356
10.1002/14651858.CD004677.PUB3
P407
P577
2013-08-20T00:00:00Z